Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0OQ2S
|
|||
Drug Name |
PMID26882240-Compound-14
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ELARA PHARMACEUTICALS GMBH [DE]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H21N3O3S
|
|||
Canonical SMILES |
CC1=NC=C(C=C1)C2=CC3=C(C=C2)OCCN3S(=O)(=O)C4=CC5=C(C=C4)N(C=C5)C
|
|||
InChI |
1S/C23H21N3O3S/c1-16-3-4-19(15-24-16)17-5-8-23-22(14-17)26(11-12-29-23)30(27,28)20-6-7-21-18(13-20)9-10-25(21)2/h3-10,13-15H,11-12H2,1-2H3
|
|||
InChIKey |
FPMLAMSVUUIGOG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Hypoxia-inducible factor 1 (HIF-1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Hypoxia-inducible factor 1 (HIF-1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).Expert Opin Ther Pat. 2016;26(3):309-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.